首页   >  
Protease/Metabolic Enzyme
  • Others Pathway
  >  
Proteasome
  • Autophagy
  >   枸橼酸艾莎佐米
Ixazomib citrate 结构式

枸橼酸艾莎佐米

参考资料 仅供科学研究,不可用于个人用途。
货号 :BCP16600CAS号 :1239908-20-3纯度:98%
全国免运费!免费咨询:400-099-8200 或 手机联系:13472751340
即时询价 ×

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • 基本信息与产品描述
CAS号 1239908-20-3 货号 BCP16600
中文名 枸橼酸艾莎佐米
英文名 Ixazomib citrate
中文别名 伊莎佐米柠檬酸盐;
英文别名 MLN9708; MLN-9708; MLN 9708;Ixazomib-prodrug;
SMILES O=C(O)CC1(CC(O)=O)OB([C@@H](NC(CNC(C2=CC(Cl)=CC=C2Cl)=O)=O)CC(C)C)OC1=O
化学名称
分子式 C20H23BCl2N2O9 分子量 517.119
纯度 98% 配送 惯例下常温包邮
产品描述 MLN9708, also known as ixazomib citrate, is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. MLN9708, after hydrolyzing to pharmacologically active MLN2238 (ixazomib), is a next-generation proteasome inhibitor with demonstrated preclinical and clinical antimyeloma activity. MLN9708, compared with bortezomib, has improved pharmacokinetics, pharmacodynamics, and antitumor activity in preclinical studies.
  • 技术资料和支持
在购买和使用瀚香生物产品的过程中,您遇到的任何问题,都可以咨询我们的免费热线:400-099-8200,或者和我们的客服 。 我们竭诚解决您的一切疑惑,保证您的舒心顺畅。

相关产品推荐

查看更多 >

Tags:Ixazomib citrate 供应商,Ixazomib citrate 购买,Ixazomib citrate 生产,Ixazomib citrate 批量,Ixazomib citrate 供应,Ixazomib citrate 订购,Ixazomib citrate 采购

2853530910